Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
APPLE: Aspirin to Prevent Pregnancy Loss and Preeclampsia
NCT06408181Phase 3Recruiting
- Sponsor
- University of Pennsylvania
- Start
- Jun 2024
- Primary completion
- Jun 2029
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of aspirin in preeclampsia, Pregnancy loss, sponsored by University of Pennsylvania. Started Jun 2024; status: recruiting.
02
Drugs
aspirin
03
Conditions
preeclampsiaPregnancy loss
Beyond the preview
Go deeper on NCT06408181.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06408181.